Related Experiment Videos
Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects,
M J Gitlin1, K H Nuechterlein, J Mintz
1Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 90095-6968, USA. mgitlin@mednet.ucla.edu
Rationale:
The utility of fluphenazine levels during maintenance treatment of schizophrenia is still unclear.
Objectives:
This study investigated the relationship between fluphenazine levels and a variety of clinical measures during maintenance treatment of schizophrenia.
Methods:
Fluphenazine levels, side effects, depression and psychosocial outcome were measured at five time points over approximately 1 year in 59 recent onset schizophrenic patients treated with a maintenance dose of injectable fluphenazine decanoate. Negative symptoms were evaluated at the 1-year endpoint.
Results:
Fluphenazine levels showed marked intraindividual variability even when measurements were restricted to the second 6 months of treatment, by which time steady state levels should have been achieved. No consistent relationship was found between fluphenazine levels and any of the outcome measures.
Conclusions:
The results of this study suggest that fluphenazine plasma levels do not routinely add relevant clinical information beyond that of dose in evaluating potential side effects or negative consequences during maintenance treatment with the decanoate form of the medication.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
Mania and Antimanic Drugs: Overview